Simple cognitive test and EMR tool boost dementia care actions in primary care setting, trial finds
By
Kristen Fischer
Jun 07, 2024
A five-minute cognitive assessment test and an electronic medical record (EMR) decision-making add-on system improved dementia diagnosis and care, according to a clinical trial.
UCSF telehealth program cuts costs and improves outcomes for seniors with dementias
By
Aaron Dorman
Sep 25, 2023
A telehealth program out of UCSF has achieved the coveted goal of cutting costs and improving patient care for seniors with dementia, researchers state.
More news for Wednesday, Feb. 22
By
Kimberly Bonvissuto
Feb 22, 2023
Congressman tells AG Garland that Esformes case is ‘political’ … FHCA unveils 2023 legislative priorities … Medicare advisers suggest tweak to coverage process for Alzheimer’s drugs … Schumer...
Promising Alzheimer’s treatment options lead to expanded PET scan recommendations
By
Aaron Dorman
Jul 24, 2023
CMS is now recommending expanding coverage for PET scans by lifting the current single-test limit.
Caregivers, seniors with Alzheimer’s to benefit from ‘Rippl’ effect, access to 24/7 helpline
By
Aaron Dorman
Apr 09, 2024
A new dementia care platform will get telehealth to more seniors, and their caregivers, including access to a 24/7 helpline.
Heath-tech startup to pilot a ‘tech-enabled care pathway’ for seniors with dementia
By
Aaron Dorman
Nov 27, 2023
A new startup that specializes in dementia care management joins the ranks of senior-care software companies that look to use AI.
CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Brain imaging company teases tech that will analyze side effects of new dementia drugs
By
Aaron Dorman
Nov 28, 2023
AI-enabled brain imaging technology will be launched next year to evaluate the side effects of new Alzheimer’s and dementia drugs.
More news for Tuesday, Dec. 6
Dec 06, 2016
Women with dementia receive less medical attention … The Senate was expected to vote on the 21st Century Cures legislation today … 89% of adults over 50 own some type of mobile device and 73%...